Clinical trial
The Effect of Intracoronary Autologous Bone Marrow Derived Mononuclear Stem Cell Transplantation in Heart Failure (HF) Patients
NCT03145402 is registered in ClinicalTrials.gov with SCARM Institute, Tabriz, Iran as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Intracoronary Autologous Bone Marrow Derived Mononuclear Stem Cell Transplantation in Heart Failure (HF) Patients
- Lead sponsor
- SCARM Institute, Tabriz, Iran
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- October 20, 2020
- Completion date
- October 2, 2021
- Enrollment
- 5 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.